Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.
Illumina launched the Billion Cell Atlas to train AI on one billion single cells. AstraZeneca, Merck and Lilly are founding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback